In summary, we identified a previously undescribed signaling pathway of the USP22-PPARγ-ACLY/ACC axis that plays an important role in lipogenesis and HCC tumorigenesis and provides an option for cancer therapy targeting fatty acid synthesis. This evidence concerns the gene USP22 and cancer.